BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chang L, Graham PH, Hao J, Ni J, Bucci J, Cozzi PJ, Kearsley JH, Li Y. Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance. Cell Death Dis. 2013;4:e875. [PMID: 24157869 DOI: 10.1038/cddis.2013.407] [Cited by in Crossref: 203] [Cited by in F6Publishing: 210] [Article Influence: 25.4] [Reference Citation Analysis]
Number Citing Articles
1 Beretov J, Wasinger VC, Millar EK, Schwartz P, Graham PH, Li Y. Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach. PLoS One 2015;10:e0141876. [PMID: 26544852 DOI: 10.1371/journal.pone.0141876] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 7.8] [Reference Citation Analysis]
2 Bruyère R. [Gynecologic examinations]. Union Med Can 1965;94:799-804. [PMID: 5836072 [PMID: 5836072 DOI: 10.3390/cancers10020040] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
3 Nakamura S, Kanda M, Koike M, Shimizu D, Umeda S, Hattori N, Hayashi M, Tanaka C, Kobayashi D, Yamada S, Omae K, Kodera Y. KCNJ15 Expression and Malignant Behavior of Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2020;27:2559-68. [PMID: 32052303 DOI: 10.1245/s10434-019-08189-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Marcucci F, Stassi G, De Maria R. Epithelial-mesenchymal transition: a new target in anticancer drug discovery. Nat Rev Drug Discov. 2016;15:311-325. [PMID: 26822829 DOI: 10.1038/nrd.2015.13] [Cited by in Crossref: 182] [Cited by in F6Publishing: 184] [Article Influence: 36.4] [Reference Citation Analysis]
5 Zhao SG, Yu M, Spratt DE, Chang SL, Feng FY, Kim MM, Speers CW, Carlson BL, Mladek AC, Lawrence TS, Sarkaria JN, Wahl DR. Xenograft-based, platform-independent gene signatures to predict response to alkylating chemotherapy, radiation, and combination therapy for glioblastoma. Neuro Oncol 2019;21:1141-9. [PMID: 31121035 DOI: 10.1093/neuonc/noz090] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
6 Jiang P, Yang X, Li Y, Chen J. miRNA-216 knockdown has effects to suppress osteosarcoma via stimulating PTEN. Food Sci Nutr 2020;8:4708-16. [PMID: 32994932 DOI: 10.1002/fsn3.1587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Huang B, Fu SJ, Fan WZ, Wang ZH, Chen ZB, Guo SJ, Chen JX, Qiu SP. PKCε inhibits isolation and stemness of side population cells via the suppression of ABCB1 transporter and PI3K/Akt, MAPK/ERK signaling in renal cell carcinoma cell line 769P. Cancer Lett 2016;376:148-54. [PMID: 27037060 DOI: 10.1016/j.canlet.2016.03.041] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
8 Gray M, Turnbull AK, Ward C, Meehan J, Martínez-Pérez C, Bonello M, Pang LY, Langdon SP, Kunkler IH, Murray A, Argyle D. Development and characterisation of acquired radioresistant breast cancer cell lines. Radiat Oncol 2019;14:64. [PMID: 30987655 DOI: 10.1186/s13014-019-1268-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
9 Amey CL, Karnoub AE. Targeting Cancer Stem Cells-A Renewed Therapeutic Paradigm. Oncol Hematol Rev 2017;13:45-55. [PMID: 33959299 DOI: 10.17925/ohr.2017.13.01.45] [Reference Citation Analysis]
10 Yilmazer A. Evaluation of cancer stemness in breast cancer and glioblastoma spheroids in vitro. 3 Biotech 2018;8:390. [PMID: 30175027 DOI: 10.1007/s13205-018-1412-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
11 Nakamura KD, Tilli TM, Wanderley JL, Palumbo A Jr, Mattos RM, Ferreira AC, Klumb CE, Nasciutti LE, Gimba ER. Osteopontin splice variants expression is involved on docetaxel resistance in PC3 prostate cancer cells. Tumour Biol 2016;37:2655-63. [PMID: 26404131 DOI: 10.1007/s13277-015-4095-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
12 Beck TN, Chikwem AJ, Solanki NR, Golemis EA. Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer. Physiol Genomics 2014;46:699-724. [PMID: 25096367 DOI: 10.1152/physiolgenomics.00062.2014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
13 Ding S, Wang W, Wang X, Liang Y, Liu L, Ye Y, Yang J, Gao H, Zhuge Q. Dopamine Burden Triggers Neurodegeneration via Production and Release of TNF-α from Astrocytes in Minimal Hepatic Encephalopathy. Mol Neurobiol 2016;53:5324-43. [PMID: 26433377 DOI: 10.1007/s12035-015-9445-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
14 Luszczak S, Kumar C, Sathyadevan VK, Simpson BS, Gately KA, Whitaker HC, Heavey S. PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer. Signal Transduct Target Ther 2020;5:7. [PMID: 32296034 DOI: 10.1038/s41392-020-0109-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
15 Lu Y, Li T, Wei G, Liu L, Chen Q, Xu L, Zhang K, Zeng D, Liao R. The long non-coding RNA NEAT1 regulates epithelial to mesenchymal transition and radioresistance in through miR-204/ZEB1 axis in nasopharyngeal carcinoma. Tumour Biol 2016;37:11733-41. [PMID: 27020592 DOI: 10.1007/s13277-015-4773-4] [Cited by in Crossref: 91] [Cited by in F6Publishing: 100] [Article Influence: 18.2] [Reference Citation Analysis]
16 Hou KZ, Fu ZQ, Gong H. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition. World J Gastroenterol 2015; 21(2): 475-483 [PMID: 25593462 DOI: 10.3748/wjg.v21.i2.475] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
17 Luo J, Chen J, He L. mir-129-5p Attenuates Irradiation-Induced Autophagy and Decreases Radioresistance of Breast Cancer Cells by Targeting HMGB1. Med Sci Monit 2015;21:4122-9. [PMID: 26720492 DOI: 10.12659/msm.896661] [Cited by in Crossref: 46] [Cited by in F6Publishing: 29] [Article Influence: 7.7] [Reference Citation Analysis]
18 Zhang Y, He L, Sadagopan A, Ma T, Dotti G, Wang Y, Zheng H, Gao X, Wang D, Deleo AB, Fan S, Sun R, Yu L, Zhang L, Wang G, Ferrone S, Wang X. Targeting Radiation-Resistant Prostate Cancer Stem Cells by B7-H3 CAR T Cells. Mol Cancer Ther 2021;20:577-88. [DOI: 10.1158/1535-7163.mct-20-0446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Marcucci F, Rumio C, Lefoulon F. Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical Appraisal. Front Oncol 2016;6:115. [PMID: 27242955 DOI: 10.3389/fonc.2016.00115] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
20 Konings K, Vandevoorde C, Baselet B, Baatout S, Moreels M. Combination Therapy With Charged Particles and Molecular Targeting: A Promising Avenue to Overcome Radioresistance. Front Oncol 2020;10:128. [PMID: 32117774 DOI: 10.3389/fonc.2020.00128] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
21 Najafi M, Farhood B, Mortezaee K. Cancer stem cells (CSCs) in cancer progression and therapy. J Cell Physiol 2019;234:8381-95. [DOI: 10.1002/jcp.27740] [Cited by in Crossref: 117] [Cited by in F6Publishing: 114] [Article Influence: 39.0] [Reference Citation Analysis]
22 Eustace NJ, Anderson JC, Warram JM, Widden HN, Pedersen RT, Alrefai H, Patel Z, Hicks PH, Placzek WJ, Gillespie GY, Hjelmeland AB, Willey CD. A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma. Oncogene 2020;39:6961-74. [PMID: 33077834 DOI: 10.1038/s41388-020-01511-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
23 Song N, Jing W, Li C, Bai M, Cheng Y, Li H, Hou K, Li Y, Wang K, Li Z, Liu Y, Qu X, Che X. ZEB1 inhibition sensitizes cells to the ATR inhibitor VE-821 by abrogating epithelial-mesenchymal transition and enhancing DNA damage. Cell Cycle 2018;17:595-604. [PMID: 29157079 DOI: 10.1080/15384101.2017.1404206] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
24 Selbo PK, Bostad M, Olsen CE, Edwards VT, Høgset A, Weyergang A, Berg K. Photochemical internalisation, a minimally invasive strategy for light-controlled endosomal escape of cancer stem cell-targeting therapeutics. Photochem Photobiol Sci 2015;14:1433-50. [DOI: 10.1039/c5pp00027k] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
25 Bi L, Wang H, Tian Y. Silencing FAM135B enhances radiosensitivity of esophageal carcinoma cell. Gene 2021;772:145358. [PMID: 33340561 DOI: 10.1016/j.gene.2020.145358] [Reference Citation Analysis]
26 Saga R, Matsuya Y, Takahashi R, Hasegawa K, Date H, Hosokawa Y. Analysis of the high-dose-range radioresistance of prostate cancer cells, including cancer stem cells, based on a stochastic model. J Radiat Res 2019;60:298-307. [PMID: 31034058 DOI: 10.1093/jrr/rrz011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
27 Pal D, Tyagi A, Chandrasekaran B, Alattasi H, Ankem MK, Sharma AK, Damodaran C. Suppression of Notch1 and AKT mediated epithelial to mesenchymal transition by Verrucarin J in metastatic colon cancer. Cell Death Dis 2018;9:798. [PMID: 30038258 DOI: 10.1038/s41419-018-0810-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
28 Wu SJ, Arundhathi A, Wang HC, Chen CY, Cheng TM, Yuan SF, Wang YM. Migration and invasion of NSCLC suppressed by the downregulation of Src/focal adhesion kinase using single, double and tetra domain anti- CEACAM6 antibodies. Transl Oncol 2021;14:101057. [PMID: 33934053 DOI: 10.1016/j.tranon.2021.101057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Taussky D, Lambert C, Meissner N, Bahary JP, Delouya G. Risk factors for biochemical recurrence after a tissue-ablative prostate-specific antigen <0.2 ng/mL. Brachytherapy 2018;17:794-8. [PMID: 30153914 DOI: 10.1016/j.brachy.2018.05.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Chen L, Wang C, Zhang X, Gao K, Liu R, Shi B, Hou P. AIB1 Genomic Amplification Predicts Poor Clinical Outcomes in Female Glioma Patients. J Cancer 2016;7:2052-60. [PMID: 27877220 DOI: 10.7150/jca.16069] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
31 Meel MH, Schaper SA, Kaspers GJL, Hulleman E. Signaling pathways and mesenchymal transition in pediatric high-grade glioma. Cell Mol Life Sci 2018;75:871-87. [PMID: 29164272 DOI: 10.1007/s00018-017-2714-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
32 Liu Z, Mai C, Yang H, Zhen Y, Yu X, Hua S, Wu Q, Jiang Q, Zhang Y, Song X, Fang W. Candidate tumour suppressor CCDC19 regulates miR-184 direct targeting of C-Myc thereby suppressing cell growth in non-small cell lung cancers. J Cell Mol Med 2014;18:1667-79. [PMID: 24976536 DOI: 10.1111/jcmm.12317] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
33 De M, Ghosh S, Sen T, Shadab M, Banerjee I, Basu S, Ali N. A Novel Therapeutic Strategy for Cancer Using Phosphatidylserine Targeting Stearylamine-Bearing Cationic Liposomes. Mol Ther Nucleic Acids 2018;10:9-27. [PMID: 29499959 DOI: 10.1016/j.omtn.2017.10.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
34 Green BJ, Nguyen V, Atenafu E, Weeber P, Duong BTV, Thiagalingam P, Labib M, Mohamadi RM, Hansen AR, Joshua AM, Kelley SO. Phenotypic Profiling of Circulating Tumor Cells in Metastatic Prostate Cancer Patients Using Nanoparticle-Mediated Ranking. Anal Chem 2019;91:9348-55. [DOI: 10.1021/acs.analchem.9b01697] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
35 Bhuvanalakshmi G, Arfuso F, Millward M, Dharmarajan A, Warrier S. Secreted frizzled-related protein 4 inhibits glioma stem-like cells by reversing epithelial to mesenchymal transition, inducing apoptosis and decreasing cancer stem cell properties. PLoS One 2015;10:e0127517. [PMID: 26030909 DOI: 10.1371/journal.pone.0127517] [Cited by in Crossref: 26] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
36 Chen QY, Jiao DM, Zhu Y, Hu H, Wang J, Tang X, Chen J, Yan L. Identification of carcinogenic potential-associated molecular mechanisms in CD133(+) A549 cells based on microRNA profiles. Tumour Biol 2016;37:521-30. [PMID: 26227219 DOI: 10.1007/s13277-015-3675-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
37 Szatkowska M, Krupa R. Regulation of DNA Damage Response and Homologous Recombination Repair by microRNA in Human Cells Exposed to Ionizing Radiation. Cancers (Basel) 2020;12:E1838. [PMID: 32650508 DOI: 10.3390/cancers12071838] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
38 Sundahl N, Duprez F, Ost P, De Neve W, Mareel M. Effects of radiation on the metastatic process. Mol Med 2018;24:16. [PMID: 30134800 DOI: 10.1186/s10020-018-0015-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
39 Robles-Flores M, Moreno-Londoño AP, Castañeda-Patlán MC. Signaling Pathways Involved in Nutrient Sensing Control in Cancer Stem Cells: An Overview. Front Endocrinol (Lausanne) 2021;12:627745. [PMID: 33828530 DOI: 10.3389/fendo.2021.627745] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
40 Cao W, Li J, Yang K, Cao D. An overview of autophagy: Mechanism, regulation and research progress. Bull Cancer 2021;108:304-22. [PMID: 33423775 DOI: 10.1016/j.bulcan.2020.11.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
41 Zielinska HA, Bahl A, Holly JM, Perks CM. Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor-binding protein 3? Breast Cancer (Dove Med Press) 2015;7:9-19. [PMID: 25632238 DOI: 10.2147/BCTT.S43932] [Cited by in Crossref: 5] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
42 Zhou HM, Sun QX, Cheng Y. Paeonol enhances the sensitivity of human ovarian cancer cells to radiotherapy-induced apoptosis due to downregulation of the phosphatidylinositol-3-kinase/Akt/phosphatase and tensin homolog pathway and inhibition of vascular endothelial growth factor. Exp Ther Med 2017;14:3213-20. [PMID: 28912871 DOI: 10.3892/etm.2017.4877] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
43 Blagosklonny MV. Koschei the immortal and anti-aging drugs. Cell Death Dis 2014;5:e1552. [PMID: 25476900 DOI: 10.1038/cddis.2014.520] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
44 Johansson AC, La Fleur L, Melissaridou S, Roberg K. The relationship between EMT, CD44high /EGFRlow phenotype, and treatment response in head and neck cancer cell lines. J Oral Pathol Med 2016;45:640-6. [PMID: 26757432 DOI: 10.1111/jop.12423] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
45 Sonis ST, Hashemi S, Epstein JB, Nair RG, Raber-durlacher JE. Could the biological robustness of low level laser therapy (Photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients. Oral Oncology 2016;54:7-14. [DOI: 10.1016/j.oraloncology.2016.01.005] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 13.6] [Reference Citation Analysis]
46 Kaushik NK, Kaushik N, Yoo KC, Uddin N, Kim JS, Lee SJ, Choi EH. Low doses of PEG-coated gold nanoparticles sensitize solid tumors to cold plasma by blocking the PI3K/AKT-driven signaling axis to suppress cellular transformation by inhibiting growth and EMT. Biomaterials 2016;87:118-30. [PMID: 26921841 DOI: 10.1016/j.biomaterials.2016.02.014] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 9.4] [Reference Citation Analysis]
47 Zhao RS, Wang W, Li JP, Liu CM, He L. Gelsolin Promotes Radioresistance in Non-Small Cell Lung Cancer Cells Through Activation of Phosphoinositide 3-Kinase/Akt Signaling. Technol Cancer Res Treat 2017;16:512-8. [PMID: 27121073 DOI: 10.1177/1533034616643884] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
48 Park H, Lee S, Shrestha P, Kim J, Park JA, Ko Y, Ban YH, Park DY, Ha SJ, Koh GY, Hong VS, Mochizuki N, Kim YM, Lee W, Kwon YG. AMIGO2, a novel membrane anchor of PDK1, controls cell survival and angiogenesis via Akt activation. J Cell Biol 2015;211:619-37. [PMID: 26553931 DOI: 10.1083/jcb.201503113] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
49 Marengo B, Nitti M, Furfaro AL, Colla R, Ciucis CD, Marinari UM, Pronzato MA, Traverso N, Domenicotti C. Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy. Oxid Med Cell Longev 2016;2016:6235641. [PMID: 27418953 DOI: 10.1155/2016/6235641] [Cited by in Crossref: 121] [Cited by in F6Publishing: 114] [Article Influence: 24.2] [Reference Citation Analysis]
50 Ahmad P, Sana J, Slavik M, Slampa P, Smilek P, Slaby O. MicroRNAs Involvement in Radioresistance of Head and Neck Cancer. Dis Markers 2017;2017:8245345. [PMID: 28325958 DOI: 10.1155/2017/8245345] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
51 Lee HW, Cho HJ, Lee SJ, Song HJ, Cho HJ, Park MC, Seol HJ, Lee J, Kim S, Lee HM, Choi HY, Nam D, Joo KM. Tpl2 induces castration resistant prostate cancer progression and metastasis: Tpl2 in Prostate Cancer Progression and Metastasis. Int J Cancer 2015;136:2065-77. [DOI: 10.1002/ijc.29248] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
52 Piao L, Li H, Feng Y, Li X, Cui Y, Xuan Y. Leucine Zipper-EF-Hand Containing Transmembrane Protein 1 Is a Potential Prognostic Biomarker and Promotes Cell Progression in Prostate Cancer. Cancer Manag Res 2020;12:1649-60. [PMID: 32184668 DOI: 10.2147/CMAR.S236482] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
53 Patel S, Patel A, Nair A, Shah K, Shah K, Tanavde V, Rawal R. Salinomycin mediated therapeutic targeting of circulating stem like cell population in oral cancer. J Biomol Struct Dyn 2021;:1-13. [PMID: 34308783 DOI: 10.1080/07391102.2021.1957018] [Reference Citation Analysis]
54 Kilic S, Cracchiolo B, Gabel M, Haffty B, Mahmoud O. The relevance of molecular biomarkers in cervical cancer patients treated with radiotherapy. Ann Transl Med 2015;3:261. [PMID: 26605307 DOI: 10.3978/j.issn.2305-5839.2015.10.18] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
55 Hsu TH, Jiang SY, Chang WL, Eckert RL, Scharadin TM, Chang TC. Involvement of RARRES3 in the regulation of Wnt proteins acylation and signaling activities in human breast cancer cells. Cell Death Differ 2015;22:801-14. [PMID: 25361079 DOI: 10.1038/cdd.2014.175] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
56 Cojoc M, Mäbert K, Muders MH, Dubrovska A. A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms. Seminars in Cancer Biology 2015;31:16-27. [DOI: 10.1016/j.semcancer.2014.06.004] [Cited by in Crossref: 209] [Cited by in F6Publishing: 210] [Article Influence: 34.8] [Reference Citation Analysis]
57 Steinbichler TB, Alshaimaa A, Maria MV, Daniel D, Herbert R, Jozsef D, Ira-Ida S. Epithelial-mesenchymal crosstalk induces radioresistance in HNSCC cells. Oncotarget 2018;9:3641-52. [PMID: 29423072 DOI: 10.18632/oncotarget.23248] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
58 Xi R, Pan S, Chen X, Hui B, Zhang L, Fu S, Li X, Zhang X, Gong T, Guo J, Zhang X, Che S. HPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivo. Oncotarget 2016;7:57050-65. [PMID: 27489353 DOI: 10.18632/oncotarget.10959] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
59 Kim TW, Hong DW, Hong SH. PB01 suppresses radio-resistance by regulating ATR signaling in human non-small-cell lung cancer cells. Sci Rep 2021;11:12093. [PMID: 34103635 DOI: 10.1038/s41598-021-91716-z] [Reference Citation Analysis]
60 Aghajani M, Mokhtarzadeh A, Aghebati-Maleki L, Mansoori B, Mohammadi A, Safaei S, Asadzadeh Z, Hajiasgharzadeh K, Khaze Shahgoli V, Baradaran B. CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel. Mol Biol Rep 2020;47:3691-703. [PMID: 32246247 DOI: 10.1007/s11033-020-05411-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
61 Jiao D, Wang J, Lu W, Tang X, Chen J, Mou H, Chen QY. Curcumin inhibited HGF-induced EMT and angiogenesis through regulating c-Met dependent PI3K/Akt/mTOR signaling pathways in lung cancer. Mol Ther Oncolytics 2016;3:16018. [PMID: 27525306 DOI: 10.1038/mto.2016.18] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 16.2] [Reference Citation Analysis]
62 Yao M, Rogers L, Suchowerska N, Choe D, Al-Dabbas MA, Narula RS, Lyons JG, Sved P, Li Z, Dong Q. Sensitization of prostate cancer to radiation therapy: Molecules and pathways to target. Radiother Oncol 2018;128:283-300. [PMID: 29929859 DOI: 10.1016/j.radonc.2018.05.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
63 Chen X, Liu Y, Zhang Q, Liu B, Cheng Y, Zhang Y, Sun Y, Liu J. Exosomal miR-590-3p derived from cancer-associated fibroblasts confers radioresistance in colorectal cancer. Mol Ther Nucleic Acids 2021;24:113-26. [PMID: 33738143 DOI: 10.1016/j.omtn.2020.11.003] [Reference Citation Analysis]
64 Mitra A, Satelli A, Xia X, Cutrera J, Mishra L, Li S. Cell-surface Vimentin: A mislocalized protein for isolating csVimentin(+) CD133(-) novel stem-like hepatocellular carcinoma cells expressing EMT markers. Int J Cancer. 2015;137:491-496. [PMID: 25487874 DOI: 10.1002/ijc.29382] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 6.6] [Reference Citation Analysis]
65 López-Gómez M, Casado E, Muñoz M, Alcalá S, Moreno-Rubio J, D'Errico G, Jiménez-Gordo AM, Salinas S, Sainz B Jr. Current evidence for cancer stem cells in gastrointestinal tumors and future research perspectives. Crit Rev Oncol Hematol 2016;107:54-71. [PMID: 27823652 DOI: 10.1016/j.critrevonc.2016.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
66 Lai Y, Yu W, Kuo S, Ho C, Hung C, Way T, Chen C. CSC‐3436 inhibits TWIST‐induced epithelial–mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma. J Cell Physiol 2019;234:9118-29. [DOI: 10.1002/jcp.27589] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
67 Wu J, Yang Y, Gao S, Jiang H, Wang XQ, Xiao Y, Chen XH, Li P, Xu CD. ERp29 inhibits tumorigenicity by suppressing epithelial mesenchymal transition in gastric cancer. Oncotarget 2017;8:78757-66. [PMID: 29108263 DOI: 10.18632/oncotarget.20225] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
68 Fujita M, Yamada S, Imai T. Irradiation induces diverse changes in invasive potential in cancer cell lines. Seminars in Cancer Biology 2015;35:45-52. [DOI: 10.1016/j.semcancer.2015.09.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
69 Akhter MZ, Sharawat SK, Kumar V, Kochat V, Equbal Z, Ramakrishnan M, Kumar U, Mathur S, Kumar L, Mukhopadhyay A. Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM+CD45+ phenotype. Oncogene 2018;37:2089-103. [PMID: 29379166 DOI: 10.1038/s41388-017-0106-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
70 Antoniou A, Hébrant A, Dom G, Dumont JE, Maenhaut C. Cancer stem cells, a fuzzy evolving concept: a cell population or a cell property? Cell Cycle 2013;12:3743-8. [PMID: 24270846 DOI: 10.4161/cc.27305] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
71 Zhan K, Liu R, Tong H, Gao S, Yang G, Hossain A, Li T, He W. Fetuin B overexpression suppresses proliferation, migration, and invasion in prostate cancer by inhibiting the PI3K/AKT signaling pathway. Biomed Pharmacother 2020;131:110689. [PMID: 32892030 DOI: 10.1016/j.biopha.2020.110689] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Montanari M, Rossetti S, Cavaliere C, D'Aniello C, Malzone MG, Vanacore D, Di Franco R, La Mantia E, Iovane G, Piscitelli R, Muscariello R, Berretta M, Perdonà S, Muto P, Botti G, Bianchi AAM, Veneziani BM, Facchini G. Epithelial-mesenchymal transition in prostate cancer: an overview. Oncotarget 2017;8:35376-89. [PMID: 28430640 DOI: 10.18632/oncotarget.15686] [Cited by in Crossref: 87] [Cited by in F6Publishing: 86] [Article Influence: 29.0] [Reference Citation Analysis]
73 Zhao Y, Li Y, Sheng J, Wu F, Li K, Huang R, Wang X, Jiao T, Guan X, Lu Y, Chen X, Luo Z, Zhou Y, Hu H, Liu W, Du B, Miao S, Cai J, Wang L, Zhao H, Ying J, Bi X, Song W. P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs. J Exp Clin Cancer Res 2019;38:379. [PMID: 31455383 DOI: 10.1186/s13046-019-1375-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
74 Coco S, Truini A, Alama A, Dal Bello MG, Venè R, Garuti A, Carminati E, Rijavec E, Genova C, Barletta G, Sini C, Ballestrero A, Boccardo F, Grossi F. Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition. Target Oncol 2015;10:393-404. [PMID: 25341405 DOI: 10.1007/s11523-014-0344-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
75 Jing C, Fu R, Wang C, Li X, Zhang W. MRPL13 Act as a Novel Therapeutic Target and Could Promote Cell Proliferation in Non-Small Cell Lung Cancer. Cancer Manag Res 2021;13:5535-45. [PMID: 34285575 DOI: 10.2147/CMAR.S316428] [Reference Citation Analysis]
76 Mitra A, Mishra L, Li S. EMT, CTCs and CSCs in tumor relapse and drug-resistance. Oncotarget. 2015;6:10697-10711. [PMID: 25986923 DOI: 10.18632/oncotarget.4037] [Cited by in Crossref: 307] [Cited by in F6Publishing: 300] [Article Influence: 61.4] [Reference Citation Analysis]
77 Sayyed AA, Gondaliya P, Mali M, Pawar A, Bhat P, Khairnar A, Arya N, Kalia K. MiR-155 Inhibitor-Laden Exosomes Reverse Resistance to Cisplatin in a 3D Tumor Spheroid and Xenograft Model of Oral Cancer. Mol Pharm 2021;18:3010-25. [PMID: 34176265 DOI: 10.1021/acs.molpharmaceut.1c00213] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Wiechec E, Hansson KT, Alexandersson L, Jönsson JI, Roberg K. Hypoxia Mediates Differential Response to Anti-EGFR Therapy in HNSCC Cells. Int J Mol Sci 2017;18:E943. [PMID: 28468237 DOI: 10.3390/ijms18050943] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
79 Li G, Wang Y, Liu Y, Su Z, Liu C, Ren S, Deng T, Huang D, Tian Y, Qiu Y. miR-185-3p regulates nasopharyngeal carcinoma radioresistance by targeting WNT2B in vitro. Cancer Sci 2014;105:1560-8. [PMID: 25297925 DOI: 10.1111/cas.12555] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 6.0] [Reference Citation Analysis]
80 Keam SP, Caramia F, Gamell C, Paul PJ, Arnau GM, Neeson PJ, Williams SG, Haupt Y. The Transcriptional Landscape of Radiation-Treated Human Prostate Cancer: Analysis of a Prospective Tissue Cohort. Int J Radiat Oncol Biol Phys 2018;100:188-98. [PMID: 29102647 DOI: 10.1016/j.ijrobp.2017.09.037] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
81 Bhatia S, Monkman J, Toh AKL, Nagaraj SH, Thompson EW. Targeting epithelial-mesenchymal plasticity in cancer: clinical and preclinical advances in therapy and monitoring. Biochem J 2017;474:3269-306. [PMID: 28931648 DOI: 10.1042/BCJ20160782] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 9.8] [Reference Citation Analysis]
82 Ginnebaugh KR, Ahmad A, Sarkar FH. The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer. Expert Opin Ther Targets 2014;18:731-45. [PMID: 24758643 DOI: 10.1517/14728222.2014.909807] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
83 Xing S, Wang C, Tang H, Guo J, Liu X, Yi F, Liu G, Wu X. Down-regulation of PDGFRβ suppresses invasion and migration in osteosarcoma cells by influencing epithelial-mesenchymal transition. FEBS Open Bio 2020;10:1748-57. [PMID: 32580247 DOI: 10.1002/2211-5463.12915] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Sato K, Shimokawa T, Imai T. Difference in Acquired Radioresistance Induction Between Repeated Photon and Particle Irradiation. Front Oncol 2019;9:1213. [PMID: 31799186 DOI: 10.3389/fonc.2019.01213] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
85 Yang C, Zhang Z, Ye F, Mou Z, Chen X, Ou Y, Xu C, Wu S, Cheng Z, Hu J, Zou L, Jiang H. FGF18 Inhibits Clear Cell Renal Cell Carcinoma Proliferation and Invasion via Regulating Epithelial-Mesenchymal Transition. Front Oncol 2020;10:1685. [PMID: 33117668 DOI: 10.3389/fonc.2020.01685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Tian T, Li X, Zhang J. mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy. Int J Mol Sci. 2019;20:755. [PMID: 30754640 DOI: 10.3390/ijms20030755] [Cited by in Crossref: 157] [Cited by in F6Publishing: 156] [Article Influence: 78.5] [Reference Citation Analysis]
87 Zhu WB, Xiao N, Liu XJ. Dietary flavonoid tangeretin induces reprogramming of epithelial to mesenchymal transition in prostate cancer cells by targeting the PI3K/Akt/mTOR signaling pathway. Oncol Lett 2018;15:433-40. [PMID: 29375715 DOI: 10.3892/ol.2017.7307] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
88 Sunkara RR, Sarate RM, Setia P, Shah S, Gupta S, Chaturvedi P, Gera P, Waghmare SK. SFRP1 in Skin Tumor Initiation and Cancer Stem Cell Regulation with Potential Implications in Epithelial Cancers. Stem Cell Reports 2020;14:271-84. [PMID: 31928951 DOI: 10.1016/j.stemcr.2019.12.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
89 Barkovskaya A, Goodwin CM, Seip K, Hilmarsdottir B, Pettersen S, Stalnecker C, Engebraaten O, Briem E, Der CJ, Moestue SA, Gudjonsson T, Maelandsmo GM, Prasmickaite L. Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen. Mol Oncol 2021;15:2026-45. [PMID: 33759347 DOI: 10.1002/1878-0261.12951] [Reference Citation Analysis]
90 Hao J, Graham P, Chang L, Ni J, Wasinger V, Beretov J, Deng J, Duan W, Bucci J, Malouf D, Gillatt D, Li Y. Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapy. Oncotarget 2016;7:74269-85. [PMID: 27708237 DOI: 10.18632/oncotarget.12368] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
91 Chang L, Graham PH, Hao J, Ni J, Bucci J, Cozzi PJ, Kearsley JH, Li Y. PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways. Cell Death Dis 2014;5:e1437. [PMID: 25275598 DOI: 10.1038/cddis.2014.415] [Cited by in Crossref: 161] [Cited by in F6Publishing: 170] [Article Influence: 23.0] [Reference Citation Analysis]
92 Duan S, Huang W, Liu X, Liu X, Chen N, Xu Q, Hu Y, Song W, Zhou J. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways. J Exp Clin Cancer Res 2018;37:304. [PMID: 30518405 DOI: 10.1186/s13046-018-0980-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 9.7] [Reference Citation Analysis]
93 Verrill C, Cerundolo L, Mckee C, White M, Kartsonaki C, Fryer E, Morris E, Brewster S, Ratnayaka I, Marsden L, Lilja H, Muschel R, Lu X, Hamdy F, Bryant RJ. Altered expression of epithelial-to-mesenchymal transition proteins in extraprostatic prostate cancer. Oncotarget 2016;7:1107-19. [PMID: 26701730 DOI: 10.18632/oncotarget.6689] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
94 Nguyen JT, Haidar FS, Fox AL, Ray C, Mendonça DB, Kim JK, Krebsbach PH. mEAK-7 Forms an Alternative mTOR Complex with DNA-PKcs in Human Cancer. iScience 2019;17:190-207. [PMID: 31288154 DOI: 10.1016/j.isci.2019.06.029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
95 Luo XM, Xu B, Zhou ML, Bao YY, Zhou SH, Fan J, Lu ZJ. Co-Inhibition of GLUT-1 Expression and the PI3K/Akt Signaling Pathway to Enhance the Radiosensitivity of Laryngeal Carcinoma Xenografts In Vivo. PLoS One 2015;10:e0143306. [PMID: 26600164 DOI: 10.1371/journal.pone.0143306] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
96 Tan X, Chen S, Wu J, Lin J, Pan C, Ying X, Pan Z, Qiu L, Liu R, Geng R, Huang W. PI3K/AKT-mediated upregulation of WDR5 promotes colorectal cancer metastasis by directly targeting ZNF407. Cell Death Dis 2017;8:e2686. [PMID: 28300833 DOI: 10.1038/cddis.2017.111] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 9.3] [Reference Citation Analysis]
97 Zhang W, Meng Y, Liu N, Wen XF, Yang T. Insights into Chemoresistance of Prostate Cancer. Int J Biol Sci 2015;11:1160-70. [PMID: 26327810 DOI: 10.7150/ijbs.11439] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 9.0] [Reference Citation Analysis]
98 Song N, Che X, Xu L, Qu J, Zheng H, Hou K, Qu X, Liu Y. A novel function of hepatocyte growth factor in the activation of checkpoint kinase 1 phosphorylation in colon cancer cells. Mol Cell Biochem 2017;436:29-38. [PMID: 28573382 DOI: 10.1007/s11010-017-3075-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
99 Schrevel M, Corver WE, Vegter ME, Ter Haar NT, Dreef EJ, Beltman JJ, Kenter G, Bosse T, de Kroon CD, Jordanova ES. L1 cell adhesion molecule (L1CAM) is a strong predictor for locoregional recurrences in cervical cancer. Oncotarget 2017;8:87568-81. [PMID: 29152102 DOI: 10.18632/oncotarget.20976] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
100 Iskender B, Izgi K, Hizar E, Jauch J, Arslanhan A, Yuksek EH, Canatan H. Inhibition of epithelial-mesenchymal transition in bladder cancer cells via modulation of mTOR signalling. Tumour Biol 2016;37:8281-91. [PMID: 26718217 DOI: 10.1007/s13277-015-4695-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
101 Zhang P, Tang WM, Zhang H, Li YQ, Peng Y, Wang J, Liu GN, Huang XT, Zhao JJ, Li G, Li AM, Bai Y, Chen Y, Ren YX, Li GX, Wang YD, Liu SD, Wang JD. MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer. Br J Cancer 2017;117:525-34. [PMID: 28632723 DOI: 10.1038/bjc.2017.181] [Cited by in Crossref: 47] [Cited by in F6Publishing: 52] [Article Influence: 11.8] [Reference Citation Analysis]
102 Lee SY, Jeong EK, Ju MK, Jeon HM, Kim MY, Kim CH, Park HG, Han SI, Kang HS. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation. Mol Cancer 2017;16:10. [PMID: 28137309 DOI: 10.1186/s12943-016-0577-4] [Cited by in Crossref: 163] [Cited by in F6Publishing: 175] [Article Influence: 40.8] [Reference Citation Analysis]
103 Peng Y, Li L, Huang M, Duan C, Zhang L, Chen J. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells. Cell Signal 2014;26:2782-92. [PMID: 25193113 DOI: 10.1016/j.cellsig.2014.08.021] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
104 Das R, Gregory PA, Hollier BG, Tilley WD, Selth LA. Epithelial plasticity in prostate cancer: principles and clinical perspectives. Trends Mol Med 2014;20:643-51. [PMID: 25262538 DOI: 10.1016/j.molmed.2014.09.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
105 Ni J, Cheung BB, Beretov J, Duan W, Bucci J, Malouf D, Graham P, Li Y. CD44 variant 6 is associated with prostate cancer growth and chemo-/radiotherapy response in vivo. Exp Cell Res 2020;388:111850. [PMID: 31954695 DOI: 10.1016/j.yexcr.2020.111850] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Shin SP, Goh AR, Kang HG, Kim SJ, Kim JK, Kim KT, Lee JH, Bae YS, Jung YS, Lee SJ. CD200 Induces Epithelial-to-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma via β-Catenin-Mediated Nuclear Translocation. Cancers (Basel) 2019;11:E1583. [PMID: 31627350 DOI: 10.3390/cancers11101583] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
107 Zang M, Zhang B, Zhang Y, Li J, Su L, Zhu Z, Gu Q, Liu B, Yan M. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway. PLoS One. 2014;9:e112908. [PMID: 25398131 DOI: 10.1371/journal.pone.0112908] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 4.9] [Reference Citation Analysis]
108 Li W, Dong Y, Zhang B, Kang Y, Yang X, Wang H. PEBP4 silencing inhibits hypoxia-induced epithelial-to-mesenchymal transition in prostate cancer cells. Biomedicine & Pharmacotherapy 2016;81:1-6. [DOI: 10.1016/j.biopha.2016.03.030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
109 Upadhyay SK, Rai RC, Gehtori R, Paliwal A, Gautam P, Joshi P. Drug Resistance in Cancer. In: Arora G, Sajid A, Kalia VC, editors. Drug Resistance in Bacteria, Fungi, Malaria, and Cancer. Cham: Springer International Publishing; 2017. pp. 449-73. [DOI: 10.1007/978-3-319-48683-3_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
110 Catara G, Spano D. Combinatorial Strategies to Target Molecular and Signaling Pathways to Disarm Cancer Stem Cells. Front Oncol 2021;11:689131. [PMID: 34381714 DOI: 10.3389/fonc.2021.689131] [Reference Citation Analysis]
111 George S, Abrahamse H. Redox Potential of Antioxidants in Cancer Progression and Prevention. Antioxidants (Basel) 2020;9:E1156. [PMID: 33233630 DOI: 10.3390/antiox9111156] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
112 Chen X, Zeng K, Xu M, Liu X, Hu X, Xu T, He B, Pan Y, Sun H, Wang S. P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2. Cell Death Dis 2019;10:131. [PMID: 30755600 DOI: 10.1038/s41419-018-1188-3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 20.0] [Reference Citation Analysis]
113 Zhifang M, Liang W, Wei Z, Bin H, Rui T, Nan W, Shuhai Z. The androgen receptor plays a suppressive role in epithelial- mesenchymal transition of human prostate cancer stem progenitor cells. BMC Biochem 2015;16:13. [PMID: 25943311 DOI: 10.1186/s12858-015-0042-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
114 Murata K, Saga R, Monzen S, Tsuruga E, Hasegawa K, Hosokawa Y. Understanding the mechanism underlying the acquisition of radioresistance in human prostate cancer cells. Oncol Lett 2019;17:5830-8. [PMID: 31186811 DOI: 10.3892/ol.2019.10219] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
115 Li L, Gu X, Yue J, Zhao Q, Lv D, Chen H, Xu L. Acquisition of EGFR TKI resistance and EMT phenotype is linked with activation of IGF1R/NF-κB pathway in EGFR-mutant NSCLC. Oncotarget 2017;8:92240-53. [PMID: 29190911 DOI: 10.18632/oncotarget.21170] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
116 Zhang GW, Tian X, Li Y, Wang ZQ, Li XD, Zhu CY. Down-regulation of ETS2 inhibits the invasion and metastasis of renal cell carcinoma cells by inducing EMT via the PI3K/Akt signaling pathway. Biomed Pharmacother 2018;104:119-26. [PMID: 29772431 DOI: 10.1016/j.biopha.2018.05.029] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
117 Hussain SS, Huang SB, Bedolla RG, Rivas P, Basler JW, Swanson GP, Hui-Ming Huang T, Narayanasamy G, Papanikolaou N, Miyamoto H, Yeh IT, Reddick RL, Pollock BH, Ghosh R, Kumar AP. Suppression of ribosomal protein RPS6KB1 by Nexrutine increases sensitivity of prostate tumors to radiation. Cancer Lett 2018;433:232-41. [PMID: 30003927 DOI: 10.1016/j.canlet.2018.07.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
118 Zhou S, Zhang M, Zhou C, Wang W, Yang H, Ye W. The role of epithelial-mesenchymal transition in regulating radioresistance. Crit Rev Oncol Hematol 2020;150:102961. [PMID: 32361589 DOI: 10.1016/j.critrevonc.2020.102961] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
119 Park SY, Kim JY, Jang GB, Choi JH, Kim JH, Lee CJ, Lee S, Baek JH, Park KK, Kim JM, Chang HJ, Cho NC, Nam JS. Aberrant activation of the CD45-Wnt signaling axis promotes stemness and therapy resistance in colorectal cancer cells. Theranostics 2021;11:8755-70. [PMID: 34522210 DOI: 10.7150/thno.63446] [Reference Citation Analysis]
120 Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J, Zhang G, Wang X, Dong Z, Chen F, Cui H. Targeting cancer stem cell pathways for cancer therapy. Sig Transduct Target Ther 2020;5. [DOI: 10.1038/s41392-020-0110-5] [Cited by in Crossref: 183] [Cited by in F6Publishing: 180] [Article Influence: 183.0] [Reference Citation Analysis]
121 Liu R, Qu Y, Chen L, Pu J, Ma S, Zhang X, Yang Q, Shi B, Hou P, Ji M. Genomic copy number gains of ErbB family members predict poor clinical outcomes in glioma patients. Oncotarget 2017;8:92275-88. [PMID: 29190914 DOI: 10.18632/oncotarget.21228] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
122 Bostad M, Kausberg M, Weyergang A, Olsen CE, Berg K, Høgset A, Selbo PK. Light-Triggered, Efficient Cytosolic Release of IM7-Saporin Targeting the Putative Cancer Stem Cell Marker CD44 by Photochemical Internalization. Mol Pharmaceutics 2014;11:2764-76. [DOI: 10.1021/mp500129t] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
123 Kachroo N, Warren AY, Gnanapragasam VJ. Multi-transcript profiling in archival diagnostic prostate cancer needle biopsies to evaluate biomarkers in non-surgically treated men. BMC Cancer 2014;14:673. [PMID: 25227682 DOI: 10.1186/1471-2407-14-673] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
124 Bamodu OA, Chang HL, Ong JR, Lee WH, Yeh CT, Tsai JT. Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma. Cells 2020;9:E746. [PMID: 32197467 DOI: 10.3390/cells9030746] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
125 Ni J, Bucci J, Chang L, Malouf D, Graham P, Li Y. Targeting MicroRNAs in Prostate Cancer Radiotherapy. Theranostics 2017;7:3243-59. [PMID: 28900507 DOI: 10.7150/thno.19934] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 9.0] [Reference Citation Analysis]
126 Wang XC, Liu Y, Long FW, Liu LR, Fan CW. Identification of a lncRNA prognostic signature-related to stem cell index and its significance in colorectal cancer. Future Oncol 2021;17:3087-100. [PMID: 33910362 DOI: 10.2217/fon-2020-1163] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Chang L, Graham P, Hao J, Ni J, Deng J, Bucci J, Malouf D, Gillatt D, Li Y. Cancer stem cells and signaling pathways in radioresistance. Oncotarget. 2016;7:11002-11017. [PMID: 26716904 DOI: 10.18632/oncotarget.6760] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 14.5] [Reference Citation Analysis]
128 Wang L, Yang C, Chu M, Wang ZW, Xue B. Cdc20 induces the radioresistance of bladder cancer cells by targeting FoxO1 degradation. Cancer Lett 2021;500:172-81. [PMID: 33290869 DOI: 10.1016/j.canlet.2020.11.052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
129 Chen X, Liang R, Lin H, Chen K, Chen L, Tian G, Zhu X. CD166 promotes cancer stem cell-like phenotype via the EGFR/ERK1/2 pathway in the nasopharyngeal carcinoma cell line CNE-2R. Life Sci 2021;267:118983. [PMID: 33383046 DOI: 10.1016/j.lfs.2020.118983] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Uemura S, Ishida T, Thwin KKM, Yamamoto N, Tamura A, Kishimoto K, Hasegawa D, Kosaka Y, Nino N, Lin KS, Takafuji S, Mori T, Iijima K, Nishimura N. Dynamics of Minimal Residual Disease in Neuroblastoma Patients. Front Oncol 2019;9:455. [PMID: 31214500 DOI: 10.3389/fonc.2019.00455] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
131 Tsao T, Beretov J, Ni J, Bai X, Bucci J, Graham P, Li Y. Cancer stem cells in prostate cancer radioresistance. Cancer Letters 2019;465:94-104. [DOI: 10.1016/j.canlet.2019.08.020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
132 Teng B, Zhao L, Gao J, He P, Li H, Chen J, Feng Q, Yi C. 20(s)-Protopanaxadiol (PPD) increases the radiotherapy sensitivity of laryngeal carcinoma. Food Funct 2017;8:4469-77. [PMID: 29090703 DOI: 10.1039/c7fo00853h] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
133 Ondrej M, Cechakova L, Durisova K, Pejchal J, Tichy A. To live or let die: Unclear task of autophagy in the radiosensitization battle. Radiother Oncol 2016;119:265-75. [PMID: 26993419 DOI: 10.1016/j.radonc.2016.02.028] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
134 Deng J, Bai X, Feng X, Ni J, Beretov J, Graham P, Li Y. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression. BMC Cancer 2019;19:618. [PMID: 31234823 DOI: 10.1186/s12885-019-5824-9] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 21.0] [Reference Citation Analysis]
135 Fotouhi Ghiam A, Taeb S, Huang X, Huang V, Ray J, Scarcello S, Hoey C, Jahangiri S, Fokas E, Loblaw A, Bristow RG, Vesprini D, Boutros P, Liu SK. Long non-coding RNA urothelial carcinoma associated 1 (UCA1) mediates radiation response in prostate cancer. Oncotarget 2017;8:4668-89. [PMID: 27902466 DOI: 10.18632/oncotarget.13576] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 14.7] [Reference Citation Analysis]
136 Su Z, Li G, Liu C, Ren S, Deng T, Zhang S, Tian Y, Liu Y, Qiu Y. Autophagy inhibition impairs the epithelial-mesenchymal transition and enhances cisplatin sensitivity in nasopharyngeal carcinoma. Oncol Lett 2017;13:4147-54. [PMID: 28599416 DOI: 10.3892/ol.2017.5963] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
137 Chang L, Ni J, Beretov J, Wasinger VC, Hao J, Bucci J, Malouf D, Gillatt D, Graham PH, Li Y. Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach. Sci Rep 2017;7:41834. [PMID: 28225015 DOI: 10.1038/srep41834] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
138 Petragnano F, Pietrantoni I, Camero S, Codenotti S, Milazzo L, Vulcano F, Macioce G, Giordani I, Tini P, Cheleschi S, Gravina GL, Festuccia C, Rossetti A, Delle Monache S, Ordinelli A, Ciccarelli C, Mauro A, Barbara B, Antinozzi C, Schiavetti A, Maggio R, Di Luigi L, Polimeni A, Marchese C, Tombolini V, Fanzani A, Bernabò N, Megiorni F, Marampon F. Clinically relevant radioresistant rhabdomyosarcoma cell lines: functional, molecular and immune-related characterization. J Biomed Sci 2020;27:90. [PMID: 32854690 DOI: 10.1186/s12929-020-00683-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
139 Krayem M, Sabbah M, Najem A, Wouters A, Lardon F, Simon S, Sales F, Journe F, Awada A, Ghanem GE, Van Gestel D. The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma. Cancers (Basel) 2019;11:E1093. [PMID: 31374895 DOI: 10.3390/cancers11081093] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
140 Cheng W, Zhang C, Ren X, Jiang Y, Han S, Liu Y, Cai J, Li M, Wang K, Liu Y, Hu H, Li Q, Yang P, Bao Z, Wu A. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma. J Neurosurg 2017;126:249-59. [PMID: 26967788 DOI: 10.3171/2015.11.JNS15432] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
141 Lu Q, Liu Z, Li Z, Chen J, Liao Z, Wu WR, Li YW. TIPE2 Overexpression Suppresses the Proliferation, Migration, and Invasion in Prostate Cancer Cells by Inhibiting PI3K/Akt Signaling Pathway. Oncol Res 2016;24:305-13. [PMID: 27712587 DOI: 10.3727/096504016X14666990347437] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
142 Li S, Mao L, Zhao F, Yan J, Song G, Luo Q, Li Z. C19orf10 promotes malignant behaviors of human bladder carcinoma cells via regulating the PI3K/AKT and Wnt/β-catenin pathways. J Cancer 2021;12:4341-54. [PMID: 34093834 DOI: 10.7150/jca.56993] [Reference Citation Analysis]
143 Liu L, Chen L, Wu X, Li X, Song Y, Mei Q, Nie J, Han W. Low-dose DNA-demethylating agent enhances the chemosensitivity of cancer cells by targeting cancer stem cells via the upregulation of microRNA-497. J Cancer Res Clin Oncol 2016;142:1431-9. [PMID: 27075177 DOI: 10.1007/s00432-016-2157-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
144 Xie J, Liu B, Chen J, Xu Y, Zhan H, Yang F, Li W, Zhou X. Umbilical cord-derived mesenchymal stem cells alleviated inflammation and inhibited apoptosis in interstitial cystitis via AKT/mTOR signaling pathway. Biochem Biophys Res Commun 2018;495:546-52. [PMID: 29137981 DOI: 10.1016/j.bbrc.2017.11.072] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
145 Dragu DL, Necula LG, Bleotu C, Diaconu CC, Chivu-Economescu M. Therapies targeting cancer stem cells: Current trends and future challenges. World J Stem Cells 2015; 7(9): 1185-1201 [PMID: 26516409 DOI: 10.4252/wjsc.v7.i9.1185] [Cited by in F6Publishing: 85] [Reference Citation Analysis]
146 Ebili HO, Iyawe VO, Adeleke KR, Salami BA, Banjo AA, Nolan C, Rakha E, Ellis I, Green A, Agboola AOJ. Checkpoint Kinase 1 Expression Predicts Poor Prognosis in Nigerian Breast Cancer Patients. Mol Diagn Ther 2018;22:79-90. [PMID: 29075961 DOI: 10.1007/s40291-017-0302-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
147 Wang C, Yang Z, Xu E, Shen X, Wang X, Li Z, Yu H, Chen K, Hu Q, Xia X, Liu S, Guan W. Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway. Clin Transl Med 2021;11:e522. [PMID: 34459127 DOI: 10.1002/ctm2.522] [Reference Citation Analysis]
148 Liu Q, Hao Y, Du R, Hu D, Xie J, Zhang J, Deng G, Liang N, Tian T, Käsmann L, Rades D, Rim CH, Hu P, Zhang J. Radiotherapy programs neutrophils to an antitumor phenotype by inducing mesenchymal-epithelial transition. Transl Lung Cancer Res 2021;10:1424-43. [PMID: 33889520 DOI: 10.21037/tlcr-21-152] [Reference Citation Analysis]
149 Galeaz C, Totis C, Bisio A. Radiation Resistance: A Matter of Transcription Factors. Front Oncol 2021;11:662840. [PMID: 34141616 DOI: 10.3389/fonc.2021.662840] [Reference Citation Analysis]
150 Khan MI, Hamid A, Adhami VM, Lall RK, Mukhtar H. Role of epithelial mesenchymal transition in prostate tumorigenesis. Curr Pharm Des 2015;21:1240-8. [PMID: 25506896 DOI: 10.2174/1381612821666141211120326] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
151 Nagaraja SS, Krishnamoorthy V, Raviraj R, Paramasivam A, Nagarajan D. Effect of Trichostatin A on radiation induced epithelial-mesenchymal transition in A549 cells. Biochem Biophys Res Commun 2017;493:1534-41. [PMID: 28993195 DOI: 10.1016/j.bbrc.2017.10.031] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
152 Bai X, Ni J, Beretov J, Graham P, Li Y. Cancer stem cell in breast cancer therapeutic resistance. Cancer Treat Rev. 2018;69:152-163. [PMID: 30029203 DOI: 10.1016/j.ctrv.2018.07.004] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 22.3] [Reference Citation Analysis]
153 Yadav S, Kowolik CM, Lin M, Zuro D, Hui SK, Riggs AD, Horne DA. SMC1A is associated with radioresistance in prostate cancer and acts by regulating epithelial-mesenchymal transition and cancer stem-like properties. Mol Carcinog 2019;58:113-25. [PMID: 30242889 DOI: 10.1002/mc.22913] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
154 Wang R, Lu X, Yu R. Lycopene Inhibits Epithelial-Mesenchymal Transition and Promotes Apoptosis in Oral Cancer via PI3K/AKT/m-TOR Signal Pathway. Drug Des Devel Ther 2020;14:2461-71. [PMID: 32606612 DOI: 10.2147/DDDT.S251614] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
155 Babaei G, Aziz SG, Jaghi NZZ. EMT, cancer stem cells and autophagy; The three main axes of metastasis. Biomed Pharmacother 2021;133:110909. [PMID: 33227701 DOI: 10.1016/j.biopha.2020.110909] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
156 Gomez-Casal R, Epperly MW, Wang H, Proia DA, Greenberger JS, Levina V. Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibition. Oncotarget 2015;6:44306-22. [PMID: 26517240 DOI: 10.18632/oncotarget.6248] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
157 Park M, Yoon HJ, Kang MC, Kwon J, Lee HW. MiR-338-5p enhances the radiosensitivity of esophageal squamous cell carcinoma by inducing apoptosis through targeting survivin. Sci Rep. 2017;7:10932. [PMID: 28883406 DOI: 10.1038/s41598-017-10977-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
158 Tahmasebi-Birgani MJ, Teimoori A, Ghadiri A, Mansoury-Asl H, Danyaei A, Khanbabaei H. Fractionated radiotherapy might induce epithelial-mesenchymal transition and radioresistance in a cellular context manner. J Cell Biochem 2018. [PMID: 30485518 DOI: 10.1002/jcb.28148] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
159 Manvati S, Mangalhara KC, Kalaiarasan P, Chopra R, Agarwal G, Kumar R, Saini SK, Kaushik M, Arora A, Kumari U, Bamezai RNK, Dhar PK. miR-145 supports cancer cell survival and shows association with DDR genes, methylation pattern, and epithelial to mesenchymal transition. Cancer Cell Int 2019;19:230. [PMID: 31516387 DOI: 10.1186/s12935-019-0933-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
160 Li Z, Zhang Y, Wang R, Zou K, Zou L. Genetic alterations in anaplastic thyroid carcinoma and targeted therapies. Exp Ther Med 2019;18:2369-77. [PMID: 31555347 DOI: 10.3892/etm.2019.7869] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
161 Carceles-Cordon M, Kelly WK, Gomella L, Knudsen KE, Rodriguez-Bravo V, Domingo-Domenech J. Cellular rewiring in lethal prostate cancer: the architect of drug resistance. Nat Rev Urol 2020;17:292-307. [PMID: 32203305 DOI: 10.1038/s41585-020-0298-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 19.0] [Reference Citation Analysis]
162 Park S, Kim YS, Kim DY, So I, Jeon J. PI3K pathway in prostate cancer: All resistant roads lead to PI3K. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2018;1870:198-206. [DOI: 10.1016/j.bbcan.2018.09.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
163 Wang L, Li S, Zhu X. Construction of Radiation Surviving/Resistant Lung Cancer Cell Lines with Equidifferent Gradient Dose Irradiation. Dose Response 2020;18:1559325820982421. [PMID: 33424518 DOI: 10.1177/1559325820982421] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Francipane MG, Lagasse E. Therapeutic potential of mTOR inhibitors for targeting cancer stem cells. Br J Clin Pharmacol 2016;82:1180-8. [PMID: 26609914 DOI: 10.1111/bcp.12844] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
165 Bielecka ZF, Maliszewska-olejniczak K, Safir IJ, Szczylik C, Czarnecka AM. Three-dimensional cell culture model utilization in cancer stem cell research: 3D cell culture models in CSCs research. Biol Rev 2017;92:1505-20. [DOI: 10.1111/brv.12293] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 13.0] [Reference Citation Analysis]
166 Shu J, Huang M, Tian Q, Shui Q, Zhou Y, Chen J. Downregulation of angiogenin inhibits the growth and induces apoptosis in human bladder cancer cells through regulating AKT/mTOR signaling pathway. J Mol Histol 2015;46:157-71. [PMID: 25564356 DOI: 10.1007/s10735-014-9608-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
167 Zecha JA, Raber-Durlacher JE, Nair RG, Epstein JB, Sonis ST, Elad S, Hamblin MR, Barasch A, Migliorati CA, Milstein DM, Genot MT, Lansaat L, van der Brink R, Arnabat-Dominguez J, van der Molen L, Jacobi I, van Diessen J, de Lange J, Smeele LE, Schubert MM, Bensadoun RJ. Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations. Support Care Cancer 2016;24:2781-92. [PMID: 26984240 DOI: 10.1007/s00520-016-3152-z] [Cited by in Crossref: 97] [Cited by in F6Publishing: 82] [Article Influence: 19.4] [Reference Citation Analysis]
168 Zhang Q, Kong Y, Yang Z, Liu Y, Liu R, Geng Y, Luo H, Zhang H, Li H, Feng S, Wang X. Preliminary study on radiosensitivity to carbon ions in human breast cancer. J Radiat Res 2020;61:399-409. [PMID: 32239160 DOI: 10.1093/jrr/rraa017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
169 Tan LLY, Chua MLK. Discovering biomarkers of radioresistance in a radiosensitive cancer: a clinical paradox in nasopharyngeal carcinoma. Ann Transl Med 2020;8:1284. [PMID: 33209864 DOI: 10.21037/atm-20-5405] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
170 Li J, Huang S, Zhang J, Feng C, Gao D, Yao B, Wu X, Fu X. Mesenchymal stem cells ameliorate inflammatory cytokine-induced impairment of AT-II cells through a keratinocyte growth factor-dependent PI3K/Akt/mTOR signaling pathway. Mol Med Rep. 2016;13:3755-3762. [PMID: 27035760 DOI: 10.3892/mmr.2016.5004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
171 Kato M, Onoyama I, Yoshida S, Cui L, Kawamura K, Kodama K, Hori E, Matsumura Y, Yagi H, Asanoma K, Yahata H, Itakura A, Takeda S, Kato K. Dual-specificity phosphatase 6 plays a critical role in the maintenance of a cancer stem-like cell phenotype in human endometrial cancer. Int J Cancer 2020;147:1987-99. [PMID: 32159851 DOI: 10.1002/ijc.32965] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
172 Balaji K, Vijayaraghavan S, Diao L, Tong P, Fan Y, Carey JP, Bui TN, Warner S, Heymach JV, Hunt KK, Wang J, Byers LA, Keyomarsi K. AXL Inhibition Suppresses the DNA Damage Response and Sensitizes Cells to PARP Inhibition in Multiple Cancers. Mol Cancer Res 2017;15:45-58. [PMID: 27671334 DOI: 10.1158/1541-7786.MCR-16-0157] [Cited by in Crossref: 46] [Cited by in F6Publishing: 27] [Article Influence: 9.2] [Reference Citation Analysis]
173 Ma Z, Liu X, Li F, Wang Y, Xu Y, Zhang M, Zhang X, Ying X, Zhang X. Perfluorooctanoic acid induces human Ishikawa endometrial cancer cell migration and invasion through activation of ERK/mTOR signaling. Oncotarget 2016;7:66558-68. [PMID: 27589685 DOI: 10.18632/oncotarget.11684] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
174 Chang L, Graham PH, Ni J, Hao J, Bucci J, Cozzi PJ, Li Y. Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance. Crit Rev Oncol Hematol 2015;96:507-17. [PMID: 26253360 DOI: 10.1016/j.critrevonc.2015.07.005] [Cited by in Crossref: 93] [Cited by in F6Publishing: 94] [Article Influence: 15.5] [Reference Citation Analysis]
175 Marcucci F, Rumio C, Corti A. Tumor cell-associated immune checkpoint molecules - Drivers of malignancy and stemness. Biochim Biophys Acta Rev Cancer 2017;1868:571-83. [PMID: 29056539 DOI: 10.1016/j.bbcan.2017.10.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
176 Rong C, Meinert ÉFRC, Hess J. Estrogen Receptor Signaling in Radiotherapy: From Molecular Mechanisms to Clinical Studies. Int J Mol Sci 2018;19:E713. [PMID: 29498642 DOI: 10.3390/ijms19030713] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
177 Su Z, Li G, Liu C, Ren S, Tian Y, Liu Y, Qiu Y. Ionizing radiation promotes advanced malignant traits in nasopharyngeal carcinoma via activation of epithelial-mesenchymal transition and the cancer stem cell phenotype. Oncol Rep 2016;36:72-8. [PMID: 27108809 DOI: 10.3892/or.2016.4768] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
178 Leiker AJ, DeGraff W, Choudhuri R, Sowers AL, Thetford A, Cook JA, Van Waes C, Mitchell JB. Radiation Enhancement of Head and Neck Squamous Cell Carcinoma by the Dual PI3K/mTOR Inhibitor PF-05212384. Clin Cancer Res 2015;21:2792-801. [PMID: 25724523 DOI: 10.1158/1078-0432.CCR-14-3279] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 6.2] [Reference Citation Analysis]
179 Ahmad R, Dhawan P, Singh AB. Cancer Stem Cell and Gastrointestinal Cancer: Current Status, Targeted Therapy and Future Implications. Biochem Pharmacol (Los Angel) 2016;5:202. [PMID: 31656694 DOI: 10.4172/2167-0501.1000202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
180 Yu CC, Hung SK, Lin HY, Chiou WY, Lee MS, Liao HF, Huang HB, Ho HC, Su YC. Targeting the PI3K/AKT/mTOR signaling pathway as an effectively radiosensitizing strategy for treating human oral squamous cell carcinoma in vitro and in vivo. Oncotarget 2017;8:68641-53. [PMID: 28978144 DOI: 10.18632/oncotarget.19817] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 9.8] [Reference Citation Analysis]
181 Rosa R, D'Amato V, De Placido S, Bianco R. Approaches for targeting cancer stem cells drug resistance. Expert Opin Drug Discov 2016;11:1201-12. [PMID: 27700193 DOI: 10.1080/17460441.2016.1243525] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
182 Mizumoto A, Yamamoto K, Nakayama Y, Takara K, Nakagawa T, Hirano T, Hirai M. Induction of epithelial-mesenchymal transition via activation of epidermal growth factor receptor contributes to sunitinib resistance in human renal cell carcinoma cell lines. J Pharmacol Exp Ther 2015;355:152-8. [PMID: 26306766 DOI: 10.1124/jpet.115.226639] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
183 Cong L, Yi J, Qiu S, Wang R, Jin S, Jiang R, Cong X. Effect of EG00229 on Radiation Resistance of Lung Adenocarcinoma Cells. J Cancer 2021;12:6105-17. [PMID: 34539883 DOI: 10.7150/jca.56123] [Reference Citation Analysis]
184 Zhou H, Yu C, Kong L, Xu X, Yan J, Li Y, An T, Gong L, Gong Y, Zhu H, Zhang H, Yang X, Li Y. B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells. Oncogene 2019;38:3371-86. [PMID: 30635656 DOI: 10.1038/s41388-018-0674-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
185 Zou K, Li Z, Zhang Y, Mu L, Chen M, Wang R, Deng W, Zou L, Liu J. β-Elemene enhances radiosensitivity in non-small-cell lung cancer by inhibiting epithelial-mesenchymal transition and cancer stem cell traits via Prx-1/NF-kB/iNOS signaling pathway. Aging (Albany NY) 2020;13:2575-92. [PMID: 33316778 DOI: 10.18632/aging.202291] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
186 Su H, Jin X, Zhang X, Zhao L, Lin B, Li L, Fei Z, Shen L, Fang Y, Pan H, Xie C. FH535 increases the radiosensitivity and reverses epithelial-to-mesenchymal transition of radioresistant esophageal cancer cell line KYSE-150R. J Transl Med. 2015;13:104. [PMID: 25888911 DOI: 10.1186/s12967-015-0464-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 5.2] [Reference Citation Analysis]
187 Dong P, Konno Y, Watari H, Hosaka M, Noguchi M, Sakuragi N. The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer. J Transl Med. 2014;12:231. [PMID: 25141911 DOI: 10.1186/s12967-014-0231-0] [Cited by in Crossref: 75] [Cited by in F6Publishing: 75] [Article Influence: 10.7] [Reference Citation Analysis]
188 Vakili‐ghartavol R, Mombeiny R, Salmaninejad A, Sorkhabadi SMR, Faridi‐majidi R, Jaafari MR, Mirzaei H. Tumor‐associated macrophages and epithelial–mesenchymal transition in cancer: Nanotechnology comes into view. J Cell Physiol 2018;233:9223-36. [DOI: 10.1002/jcp.27027] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
189 Rivera-Calderón LG, Fonseca-Alves CE, Kobayashi PE, Carvalho M, Vasconcelos RO, Laufer-Amorim R. p-mTOR, p-4EBP-1 and eIF4E expression in canine prostatic carcinoma. Res Vet Sci 2019;122:86-92. [PMID: 30476726 DOI: 10.1016/j.rvsc.2018.11.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
190 Macedo-Silva C, Benedetti R, Ciardiello F, Cappabianca S, Jerónimo C, Altucci L. Epigenetic mechanisms underlying prostate cancer radioresistance. Clin Epigenetics 2021;13:125. [PMID: 34103085 DOI: 10.1186/s13148-021-01111-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
191 Chen HT, Liu H, Mao MJ, Tan Y, Mo XQ, Meng XJ, Cao MT, Zhong CY, Liu Y, Shan H, Jiang GM. Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy. Mol Cancer 2019;18:101. [PMID: 31126310 DOI: 10.1186/s12943-019-1030-2] [Cited by in Crossref: 66] [Cited by in F6Publishing: 72] [Article Influence: 33.0] [Reference Citation Analysis]
192 Liu B, Xu L, Dai EN, Tian JX, Li JM. Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway. Biosci Rep 2018;38:BSR20181501. [PMID: 30442873 DOI: 10.1042/BSR20181501] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
193 Teng B, Jiang J, Zhao L, Gao J, Chen J, Liu Z, Wang H, Lu B. Ginsenoside PPD's Antitumor Effect via Down-Regulation of mTOR Revealed by Super-Resolution Imaging. Molecules 2017;22:E486. [PMID: 28335497 DOI: 10.3390/molecules22030486] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
194 Toulany M, Rodemann HP. Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation. Semin Cancer Biol 2015;35:180-90. [PMID: 26192967 DOI: 10.1016/j.semcancer.2015.07.003] [Cited by in Crossref: 87] [Cited by in F6Publishing: 87] [Article Influence: 14.5] [Reference Citation Analysis]
195 Yoon C, Lu J, Yi BC, Chang KK, Simon MC, Ryeom S, Yoon SS. PI3K/Akt pathway and Nanog maintain cancer stem cells in sarcomas. Oncogenesis 2021;10:12. [PMID: 33468992 DOI: 10.1038/s41389-020-00300-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
196 Kornakiewicz A, Solarek W, Bielecka ZF, Lian F, Szczylik C, Czarnecka AM. Mammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma. Curr Signal Transduct Ther 2014;8:210-8. [PMID: 25152703 DOI: 10.2174/1574362409666140206222746] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
197 Tang Z, Zeng X, Li J, Qiu S, Zhao H, Wang Z, Zheng Y. LncRNA HOXC-AS1 promotes nasopharyngeal carcinoma (NPC) progression by sponging miR-4651 and subsequently upregulating FOXO6. J Pharmacol Sci 2021;147:284-93. [PMID: 34507637 DOI: 10.1016/j.jphs.2021.08.002] [Reference Citation Analysis]
198 Zhang X, Wang J, Li X, Wang D. Lysosomes contribute to radioresistance in cancer. Cancer Lett 2018;439:39-46. [PMID: 30217567 DOI: 10.1016/j.canlet.2018.08.029] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
199 Tang Y, Chen J, Li J, Zheng Y, Zhong X, Huang S, Chen B, Peng B, Zou X, Chen X. Pristimerin synergistically sensitizes conditionally reprogrammed patient derived-primary hepatocellular carcinoma cells to sorafenib through endoplasmic reticulum stress and ROS generation by modulating Akt/FoxO1/p27kip1 signaling pathway. Phytomedicine 2021;86:153563. [PMID: 33951569 DOI: 10.1016/j.phymed.2021.153563] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
200 Ghasemi Z, Tahmasebi-Birgani MJ, Ghafari Novin A, Motlagh PE, Teimoori A, Ghadiri A, Pourghadamyari H, Sarli A, Khanbabaei H. Fractionated radiation promotes proliferation and radioresistance in bystander A549 cells but not in bystander HT29 cells. Life Sci 2020;257:118087. [PMID: 32702442 DOI: 10.1016/j.lfs.2020.118087] [Reference Citation Analysis]
201 Kang Y, He W, Ren C, Qiao J, Guo Q, Hu J, Xu H, Jiang X, Wang L. Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma. Signal Transduct Target Ther 2020;5:245. [PMID: 33093441 DOI: 10.1038/s41392-020-00340-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
202 Coppes R, Dubrovska A. Targeting Stem Cells in Radiation Oncology. Clinical Oncology 2017;29:329-34. [DOI: 10.1016/j.clon.2017.03.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
203 Aung W, Tsuji AB, Sudo H, Sugyo A, Ukai Y, Kouda K, Kurosawa Y, Furukawa T, Saga T, Higashi T. Combined treatment of pancreatic cancer xenograft with 90Y-ITGA6B4-mediated radioimmunotherapy and PI3K/mTOR inhibitor. World J Gastroenterol 2017; 23(42): 7551-7562 [PMID: 29204055 DOI: 10.3748/wjg.v23.i42.7551] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
204 Li SL, Chen X, Wu T, Zhang XW, Li H, Zhang Y, Ji ZZ. Knockdown of TMPRSS3 inhibits gastric cancer cell proliferation, invasion and EMT via regulation of the ERK1/2 and PI3K/Akt pathways. Biomed Pharmacother 2018;107:841-8. [PMID: 30142546 DOI: 10.1016/j.biopha.2018.08.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
205 Mathur A, Kumar A, Babu B, Chandna S. In vitro mesenchymal-epithelial transition in NIH3T3 fibroblasts results in onset of low-dose radiation hypersensitivity coupled with attenuated connexin-43 response. Biochim Biophys Acta Gen Subj 2018;1862:414-26. [PMID: 29154903 DOI: 10.1016/j.bbagen.2017.11.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
206 Wang L, Liu Z, Liu X, Wu Y. Microwave-assisted synthesis of chitooligosaccharide guanidine and its effect on GLUT4-dependent glucose uptake through an Akt-activated protein kinase signaling pathway in L6 skeletal muscle cells. RSC Adv 2016;6:90777-85. [DOI: 10.1039/c6ra17654b] [Cited by in Crossref: 11] [Article Influence: 2.2] [Reference Citation Analysis]
207 Haldavnekar R, Vijayakumar SC, Venkatakrishnan K, Tan B. Prediction of Cancer Stem Cell Fate by Surface-Enhanced Raman Scattering Functionalized Nanoprobes. ACS Nano 2020;14:15468-91. [PMID: 33175514 DOI: 10.1021/acsnano.0c06104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
208 Krause M, Dubrovska A, Linge A, Baumann M. Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments. Adv Drug Deliv Rev 2017;109:63-73. [PMID: 26877102 DOI: 10.1016/j.addr.2016.02.002] [Cited by in Crossref: 149] [Cited by in F6Publishing: 141] [Article Influence: 29.8] [Reference Citation Analysis]
209 Stark TW, Hensley PJ, Spear A, Pu H, Strup SS, Kyprianou N. Predictive value of epithelial-mesenchymal-transition (EMT) signature and PARP-1 in prostate cancer radioresistance. Prostate 2017;77:1583-91. [PMID: 29063620 DOI: 10.1002/pros.23435] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
210 Rane JK, Erb HH, Nappo G, Mann VM, Simms MS, Collins AT, Visakorpi T, Maitland NJ. Inhibition of the glucocorticoid receptor results in an enhanced miR-99a/100-mediated radiation response in stem-like cells from human prostate cancers. Oncotarget 2016;7:51965-80. [PMID: 27340920 DOI: 10.18632/oncotarget.10207] [Cited by in Crossref: 14] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]